Brand-Name FDA-Approved Medications Referenced on altRx altRx's source materials also reference brand-name FDA-approved medications at separate listed price points: Mounjaro: Listed at $1,249 per month per altRx's source materials Ozempic: Listed at $1,149 per month per altRx's source materials Wegovy: Listed at $1,579 per month per altRx's source materials Zepbound: Listed at $1,249 per month per altRx's source materials According to altRx's published trademark notice, Wegovy is FDA-approved for weight loss, and Ozempic is FDA-approved for type 2 diabetes treatment but may be prescribed for weight loss at the discretion of a clinician

These common mistakes can seriously affect safety and treatment success: Using the wrong injection site causing pain or nerve injury Choosing the incorrect needle size leads to poor medication delivery Injecting too quickly which increases discomfort and tissue irritation Skipping skin cleaning which raises infection risk significantly Reusing needles or disposing of them improperly after use Studies show user error causes most injection-related complications today
Efficacy and Safety of Liraglutide and Semaglutide on Weight Loss in People with Obesity or Overweight: A Systematic Review Joseph Azuri, Ariel Hammerman, Enis Aboalhasan, Ben Sluckis, Ronen Arbel (2023)
Always verify dosage protocols and patient medical history prior to administration
The testosterone and body fat cycle Low testosterone and excess body fat create a vicious cycle